Effects of dulaglutide on oxytocin plasma levels in healthy men: a secondary analysis of a randomized, double-blind, placebo-controlled crossover study
Vera Reber, Bettina Winzeler(University Hospital of Basel), Cemile Bathelt(University of Basel), Yara Emara(University Hospital of Basel), Sophia Lengsfeld(University of Basel), Laura Werlen(University Hospital of Basel), Leila Probst(University of Basel), Anne Eckert(Institut des Sciences Cognitives Marc Jeannerod), Nimmy Varghese(University of Basel)
Cited by 0
Related Papers
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
|Nature Reviews Drug Discovery|2020|982
Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity
|Alzheimer s Research & Therapy|2011|170
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
|The Lancet Respiratory Medicine|2023|124
Effects of dulaglutide on alcohol consumption during smoking cessation
|JCI Insight|2023|75
Spermidine Rescues Bioenergetic and Mitophagy Deficits Induced by Disease-Associated Tau Protein
|International Journal of Molecular Sciences|2023|33